About Transvascular
Transvascular is a company based in Menlo Park (United States) founded in 1996 was acquired by Medtronic in August 2003.. Transvascular has raised $10.8 million across 2 funding rounds from investors including Medtronic, Bessemer Venture Partners and NEA. Transvascular operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and S4 Medical, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transvascular
Transvascular has successfully raised a total of $10.8M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $10.8 million completed in May 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $10.8M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2002 | Amount | Series D - Transvascular | Valuation |
investors |
|
| Jun, 1996 | Amount | Unspecified - Transvascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Transvascular
Transvascular has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Bessemer Venture Partners and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Transvascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Transvascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transvascular Comparisons
Competitors of Transvascular
Transvascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and S4 Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of neuroprotection devices for carotid artery disease
|
|
| domain | founded_year | HQ Location |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| domain | founded_year | HQ Location |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| domain | founded_year | HQ Location |
Catheter ablation treatments for atrial fibrillation are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Transvascular
When was Transvascular founded?
Transvascular was founded in 1996.
Where is Transvascular located?
Transvascular is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Transvascular a funded company?
Transvascular is a funded company, having raised a total of $10.8M across 2 funding rounds to date.
What does Transvascular do?
Transvascular was founded in 1996 in Menlo Park, United States, with a focus on medical devices for cardiovascular conditions including coronary artery disease, congestive heart failure, and peripheral arterial disease. The CrossPoint TransAccess Catheter System, featuring phased array intravascular ultrasound imaging and a proprietary needle delivery mechanism, has been developed for targeted cell delivery to regenerate damaged heart tissue. FDA 510(k) clearance was obtained in 2002.
Who are the top competitors of Transvascular?
Transvascular's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
Who are Transvascular's investors?
Transvascular has 5 investors. Key investors include Medtronic, Bessemer Venture Partners, NEA, Johnson & Johnson Innovation – JJDC, and Three Arch Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.